Surveys: FDA relationship with life sciences improving, but recalls have hurt consumer confidence

The Food and Drug Administration (FDA) has improved its working relationship with life sciences companies, but more than one-third of U.S. consumers have lost confidence in the agency over the past two years as the result of high-profile product recalls, according to new surveys from PricewaterhouseCoopers (PwC) and Biocom.

More than one-third (38 percent) of the 50 life-sciences companies surveyed said that the overall working relationship with the FDA has improved over the past two years, while 80 percent said the FDA is providing better guidance about its expectations.

However, the FDA has failed to keep up with advancing technology, the report said. Only 8 percent of drug makers and device makers said the agency is doing enough to advance personalized medicine.

Despite eroding consumer confidence in the FDA, the survey of 1,000 U.S. adults found that 93 percent are confident about the safety and effectiveness of medical devices approved for use in the United States. Still, 56 percent said they would be willing to use drugs and devices approved outside the country before they receive FDA approval.

Almost all (97 percent) said they consider the reputation of the company making the drug or device when deciding whether or not to use it.